Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Jan, 2019 | Pages:
64 | Publisher: Grand View Research
Industry: Pharmaceutical | Report Format: Electronic (PDF)
The global pharmaceutical grade lactose market size is expected to reach USD 254.8 million by 2025 at a 4.6% CAGR during the forecast period, according to a new report by Grand View Research, Inc. Rising inclination toward preventive healthcare across the globe is estimated to boost product use over the forecast period. Increasing investments by local and foreign players in the pharmaceutical manufacturing sector, especially in developing economies such as India and Brazil, is expected to have a positive influence on industry growth. Furthermore, increased access to medication through generic drug production and development of innovative treatments for chronic diseases has resulted in the growth of the drug manufacturing industry, thereby propelling product demand. Raw material prices and operational and transportation costs are key factors that define final product price. Intense competition in the industry is expected to put pressure on prices, resulting in a decline in product price. In addition, higher product prices have lowered buyers' interest, owing to availability of substitutes, which is also expected to hamper growth. Stringent government regulations associated with the use of pharmaceutical grade lactose are expected present a barrier to entry of new players in the market. In addition, high initial cost and operation cost associated with production machinery is expected to further discourage new entrants, thereby lowering their threat. The industry is characterized by presence of major industry players focussing on research and development activities in order to reduce overall manufacturing cost by using innovative techniques. Participants have been adopting competitive strategies such as setting up new manufacturing facilities to magnify their regional presence. Further key findings from the report suggest: • Europe dominated the industry in 2017 in terms of product consumption and was valued at USD 74.7 million owing to increasing product adoption and well-established pharmaceutical industry • Asia Pacific accounted for 33.4% of the total revenue in 2017, owing to government initiatives to provide affordable prescription drugs and highest number of FDA-approved pharmaceutical lactose products in the region • The industry is characterized by increasing integration across the value chain, with participants looking to expand their footprint and strengthen their position in both manufacturing and distribution
Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
1.3. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Snapshot
Chapter 3. Market Variables, Trends, and Scope
3.1. Market Segmentation & Scope
3.2. Market Size and Growth Prospects, 2014 - 2025
3.3. Value Chain Analysis
3.4. Regulatory Framework
3.5. Market Dynamics
3.5.1. Market Driver
3.5.1.1. Growing demand for the product in infant formulations
3.5.1.2. Rising inclination towards preventive healthcare
3.5.2. Market Restraint
3.5.2.1. High product development cost and stringent government regulations pertaining to the manufacturing industry
3.6. Price Trend Analysis, 2014 - 2017
3.7. Porter's Five Forces Analysis
3.8. PESTEL Analysis
Chapter 4. Pharmaceutical Grade Lactose Market: Regional Estimates & Trend Analysis
4.1. Pharmaceutical grade lactose market: Regional overview
4.2. Pharmaceutical grade lactose market: Regional movement analysis, 2017 & 2025
4.2.1. North America
4.2.1.1. Market estimates and forecasts, 2014 - 2025 (USD Million)
4.2.1.2. U.S.
4.2.1.2.1. Market estimates and forecasts, 2014 - 2025 (USD Million)
4.2.1.3. Canada
4.2.1.3.1. Market estimates and forecasts, 2014 - 2025 (USD Million)
4.2.1.4. Mexico
4.2.1.4.1. Market estimates and forecasts, 2014 - 2025 (USD Million)
4.2.2. Europe
4.2.2.1. Market estimates and forecasts, 2014 - 2025 (USD Million)
4.2.2.2. Germany
4.2.2.2.1. Market estimates and forecasts, 2014 - 2025 (USD Million)
4.2.2.3. U.K.
4.2.2.3.1. Market estimates and forecasts, 2014 - 2025 (USD Million)
4.2.2.4. Italy
4.2.2.4.1. Market estimates and forecasts, 2014 - 2025 (USD Million)
4.2.2.5. Spain
4.2.2.5.1. Market estimates and forecasts, 2014 - 2025 (USD Million)
4.2.2.6. France
4.2.2.6.1. Market estimates and forecasts, 2014 - 2025 (USD Million)
4.2.3. Asia Pacific
4.2.3.1. Market estimates and forecasts, 2014 - 2025 (USD Million)
4.2.3.2. China
4.2.3.2.1. Market estimates and forecasts, 2014 - 2025 (USD Million)
4.2.3.3. India
4.2.3.3.1. Market estimates and forecasts, 2014 - 2025 (USD Million)
4.2.3.4. Japan
4.2.3.4.1. Market estimates and forecasts, 2014 - 2025 (USD Million)
4.2.4. Central & South America
4.2.4.1. Market estimates and forecasts, 2014 - 2025 (USD Million)
4.2.4.2. Brazil
4.2.4.2.1. Market estimates and forecasts, 2014 - 2025 (USD Million)
4.2.5. Middle East & Africa
4.2.5.1. Market estimates and forecasts, 2014 - 2025 (USD Million)
4.2.5.2. South Africa
4.2.5.2.1. Market estimates and forecasts, 2014 - 2025 (USD Million)
Chapter 5. Competitive Landscape
5.1. Vendor Landscape
5.2. Competitive Environment
5.3. Competitive Market Positioning
5.4. Strategy Framework
Chapter 6. Company Profiles
6.1. Kerry Group
6.1.1. Company overview
6.1.2. Financial performance
6.1.3. Product benchmarking
6.1.4. Strategic initiatives
6.2. Hilmar Ingredients
6.2.1. Company overview
6.2.2. Product benchmarking
6.3. Hoogwegt
6.3.1. Company overview
6.3.2. Product benchmarking
6.3.3. Strategic initiatives
6.4. FrieslandCampina Domo
6.4.1. Company overview
6.4.2. Financial performance
6.4.3. Product benchmarking
6.5. Meggle Excipients & Technology
6.5.1. Company overview
6.5.2. Product benchmarking
6.6. Milei GmbH
6.6.1. Company overview
6.6.2. Product benchmarking
6.7. Davisco Foods International, Inc.
6.7.1. Company overview
6.7.2. Product benchmarking
6.8. Fresenius Kabi Product Partnering
6.8.1. Company overview
6.8.2. Financial performance
6.8.3. Product benchmarking
6.9. Fonterra Co-Operative Group Ltd.
6.9.1. Company overview
6.9.2. Financial performance
6.9.3. Product benchmarking
6.9.4. Strategic Initiatives
6.10. Lactose (India) Limited
6.10.1. Company overview
6.10.2. Financial performance
6.10.3. Product benchmarking
6.11. Armor Pharma
6.11.1. Company overview
6.11.2. Product benchmarking
6.12. Charotar Casein Company
6.12.1. Company overview
6.12.2. Product benchmarking
6.13. Surfachem Group Ltd.
6.13.1. Company overview
6.13.2. Product benchmarking
6.14. Cepham Milk Specialities Ltd.
6.14.1. Company overview
6.14.2. Product benchmarking
6.15. ALPAVIT
6.15.1. Company overview
6.15.2. Product benchmarking
List of Tables TABLE 1 North America pharmaceutical grade lactose market estimates and forecasts, 2014 - 2025 (USD Million) TABLE 2 U.S. pharmaceutical grade lactose market estimates and forecasts, 2014 - 2025 (USD Million) TABLE 3 Canada pharmaceutical grade lactose market estimates and forecasts, 2014 - 2025 (USD Million) TABLE 4 Mexico pharmaceutical grade lactose market estimates and forecasts, 2014 - 2025 (USD Million) TABLE 5 Europe pharmaceutical grade lactose market estimates and forecasts, 2014 - 2025 (USD Million) TABLE 6 Germany pharmaceutical grade lactose market estimates and forecasts, 2014 - 2025 (USD Million) TABLE 7 U.K. pharmaceutical grade lactose market estimates and forecasts, 2014 - 2025 (USD Million) TABLE 8 Italy pharmaceutical grade lactose market estimates and forecasts, 2014 - 2025 (USD Million) TABLE 9 Spain pharmaceutical grade lactose market estimates and forecasts, 2014 - 2025 (USD Million) TABLE 10 France pharmaceutical grade lactose market estimates and forecasts, 2014 - 2025 (USD Million) TABLE 11 Asia Pacific pharmaceutical grade lactose market estimates and forecasts, 2014 - 2025 (USD Million) TABLE 12 China pharmaceutical grade lactose market estimates and forecasts, 2014 - 2025 (USD Million) TABLE 13 India pharmaceutical grade lactose market estimates and forecasts, 2014 - 2025 (USD Million) TABLE 14 Japan pharmaceutical grade lactose market estimates and forecasts, 2014 - 2025 (USD Million) TABLE 15 Central & South America pharmaceutical grade lactose market estimates and forecasts, 2014 - 2025 (USD Million) TABLE 16 Brazil pharmaceutical grade lactose market estimates and forecasts, 2014 - 2025 (USD Million) TABLE 17 Middle East & Africa pharmaceutical grade lactose market estimates and forecasts, 2014 - 2025 (USD Million) TABLE 18 South Africa pharmaceutical grade lactose market estimates and forecasts, 2014 - 2025 (USD Million)
List of Figures FIG. 1 Market snapshot FIG. 2 Market trends & outlook FIG. 3 Pharmaceutical grade lactose market - Market segmentation & scope FIG. 4 Pharmaceutical grade lactose market, 2014 - 2025 (USD Million) FIG. 5 Pharmaceutical grade lactose - Value chain analysis FIG. 6 Pharmaceutical grade lactose - Market dynamics FIG. 7 Market driver relevance analysis (Current & future impact) FIG. 8 Market restraint relevance analysis (Current & future impact) FIG. 9 Pharmaceutical granulated grade lactose price trend analysis, 2014 to 2017 FIG. 10 Pharmaceutical granulated grade lactose price trend analysis, 2014 to 2017 FIG. 11 Industry analysis - Porter's FIG. 12 Pharmaceutical grade lactose market - PESTEL analysis FIG. 13 Pharmaceutical grade lactose market: Regional overview FIG. 14 Pharmaceutical grade lactose market: Regional movement analysis, 2017 & 2025 FIG. 15 Strategy Framework of Industry Participants
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
